Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. (Q45982095)
Jump to navigation
Jump to search
scientific article published on 9 June 2012
- Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. |
scientific article published on 9 June 2012 |
|
Statements
1 reference
Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate. (English)
1 reference
Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate (English)
0 references
Tsutomu Takeuchi
1 reference
Tsukasa Matsubara
1 reference
Taisuke Nitobe
1 reference
Eiichi Suematsu
1 reference
Syuji Ohta
1 reference
Shigeru Honjo
1 reference
Tohru Abe
1 reference
Ami Yamamoto
1 reference
Nobuyuki Miyasaka
1 reference
Japan Abatacept Study Group
1 reference
9 June 2012
1 reference
1 reference
23
1 reference
2
1 reference
226-235
1 reference
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
2 references
1 reference
2 references
2 references
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference